SchmidtD., Diagnostic and therapeutic management of intractable epilepsy, in SchmidtD.MorselliP. L., Intractable Epilepsy: Experimental and Clinical aspects, L.E.R.S. Monograph series, vol. 5, Raven Press, New York, pp. 237–257, 1986.
2.
AicardiJ., Clinical approach on the treatment of patients with intractable epilepsy, EFCNS Meeting, Hyvinkää, Rantasipi, Finland, 15–18 June, 1987.
3.
EngelJ.RauschR.LiebJ.P.KuhlD.E.CrandallP.H., Correlation of criteria used for localizing epileptic foci in patients considered for surgical therapy of epilepsy, Ann. Neurol., 3:215–224, 1981.
4.
SneadC.O.BentonJ.W.MyersG.J., ACTH and prednisone in childhood seizure disorders, Neurology, 33:966–970, 1983.
5.
MirelesR.LeppikI.E., Valproate and clonazepam comedication in patients with intractable epilepsy, Epilepsia, 26:122–126, 1985.
6.
FamilusiJ.B., Preliminary Nigerian experience in the use of carbamazepine in children with intractable seizures, Epilepsia, 26:10–14, 1985.
7.
TreimanD.M.WilenskyA.J.Ben-MenachemE.OjemannL.YerbyM.BarberK. O'LearyMcCormickK.B.CereghinoJ.J.WhiteB.G.SwisherK., Efficacy of Nafimidone in the treatment of intractable partial seizures, Epilepsia, 26:607–611, 1985.
8.
ShieldsW.D.LakeJ.L.ChuganiH.T., Amantadine in the treatment of refractory epilepsy in childhood, Neurology, 35:579–581, 1985.
9.
ReynoldsE.H.ElwersR.D.C.Shor—VonS.D., Why does epilepsy become intractable?LancetX, 22:952–954, 1983.
10.
OverwegJ.RowanA.J.BinnieC.D.OostingJ.NagelkerkeN.J.D., Prediction of seizure recurrence after withdrawal of antiepileptic drugs, In: Advance in Epileptology, XII Epilepsy International Symposium, (Ed.) DamM.GramL.PenryJ.K., Raven Press, New York, pp. 503–508, 1981.
11.
KingD.W.FraniginH.F.CallagherB.B.ElsonL.MurvinA.J.SmithD.B.OomenK.J.FeldmanP.S.PowerJ., Temporal lobectomy for partial complex seizures, Neurology, 36:334–339, 1986.
12.
RodinE.A., The Prognosis of Patients with Epilepsy, Springfield, Illinois, Charles C. Thomas, 1968.
13.
GoodridgeP.M.G.ShorvonS.D., Epilepsy in a population of 6,000-1) Demography, diagnosis and classification and the role of the hospital services-2) Treatment and prognosis, Br. Med. J., 287:641–647, 1983.
14.
ShorvonS.D., The temporal aspect of prognosis in epilepsy, J. Neurol. Neurosurg. Psych., 47:1157–1165, 1984.
15.
LesserR.P.PippingerC.E.LudersH.DinnerD.S., High-dose monotherapy in treatment of intractable seizures, Neurology, 34:707–711, 1984.
16.
OverwegJ.BinnieJ.W.A.MeijerH.MeinardiH.NuittenS.T.M.SchmaltsS.WauquierA., Double blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy, Epilepsia, 25:217–222, 1986.
17.
SchmidtD.UteckK., Progabide for refractory partial epilepsy: A controlled add-on trial, Neurology, 36:217–221, 1986.
18.
RiikonenR., An unusual case of recovery from infantile spasms, Dev. Med. Child. Neurol., 26:818–821, 1984.
19.
NeuvonenP.SantavuoriP.SainioK.NotilaK., A pilot study with taltrimide in intractable epilepsy in children, EFCNS Meeting Hyvinkää, Rantasipi, Finland, 15–18 June, 1987.
20.
SantavuoriP.RiikonenR.MeretojaO.SainioK.NeuvonenP.TokolaR.A., Effect of long barbiturate anaesthesia on intractable epilepsy in children, EFCNS Meeting, Hyvinkää, Rantasipi, Finland, 15–18 June, 1987.
21.
RiikonenR.SantavuoriP.MeretojaO.SainioK.NeuvonenP.TokolaR.A., Effect of short barabiturate anaesthesia on infantile spasms, EFCNS Meeting, Hyvinkää, Rantasipi, Finland, 15–18 June 1987.
22.
MatsuoJ., Biochemical aspects of pathophysiology and treatment of intractable epilepsy in children, Brain Develop., 2:100–106, 1983.
23.
RiikonenR.DonnerM., ACTH therapy in infantile spasms: Side effects, Arch. Dis. Child, 55:664–672, 1980.
24.
FoisA.MalandriniF.MostardiniR., Further observation of treatment of infantile spasms with conticotropin, in press.
25.
ArizumiM., High dose gammaglobulin for intractable childhood epilepsy, Lancet22:162–163, 1983.
26.
DuseM.TibertiS.PlebaniA.AvanziniM.A.GardenghiM.MenegatiE.MonafoV.UgazioA.G., Ig G2 deficiency and intractable epilepsy of childhood, Monogr. Allergy, 20:128–134, 1986.